Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ)

Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ) — VMCI valuation read

Shandong Jincheng Pharmaceutical Group Co., Ltd sits at VMCI 56/100, with the Basic Materials sector median at 50. That 6-point spread is the first thing to note on 300233.SZ: it tells the reader the composite is favorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on 300233.SZ are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on 300233.SZ: 300233.SZ trades at 24.0x earnings, 33% above the Basic Materials median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 16.0% sits 6.0pp above the Basic Materials median (10.0%). The Risk read: net debt to EBITDA of 0.3x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.

300233.SZ fell 3.1% over the trailing 7 days, with a 0.0% read on a 30-day basis.